Dr. Jeanna Michelle Mascorro is a Galveston, Texas based female podiatrist who is specialized in Podiatrist. Active license number of Dr. Jeanna Michelle Mascorro for Podiatric Foot & Ankle Surgery is 2016 in Texas. Dr. Jeanna Michelle Mascorro is qualified by a Doctor of Podiatric Medicine (D.P.M.) degree, licensed by the state, and practicing within the scope of that license. She diagnose and treat foot diseases and deformities. She can perform medical, surgical and other operative procedures, prescribe corrective devices and prescribe and administer drugs and physical therapy.
Complete Profile:
Dr. Jeanna Michelle Mascorro speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1477828127
NPI Enumeration Date:
14 Mar, 2012
NPI Last Update On:
02 Dec, 2021
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Jeanna Michelle Mascorro are as mentioned below.
License Number
Specialization
State
Status
2016
Podiatric Foot & Ankle Surgery
Texas
Primary
T16-2011
Student in an Organized Health Care Education/Training Program
Texas
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Po Box 1553, Galveston, Texas
Zip:
77553
Phone Number:
409-405-1977
Fax Number:
409-405-1728
Patients can reach Dr. Jeanna Michelle Mascorro at 4920 Seawall Blvd, Ste B, Galveston, Texas or can call to book an appointment on 409-405-1977. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.